Hospital Sant Joan de Déu Barcelona
Hospital Sant Joan de Déu Barcelona
España, Barcelona
Solo para niños y adolescentes (0-18 años)
Jaume Mora Graupera
30 años de experiencia
acreditaciones :
Clínica certificada por :
El costo del tratamiento de glioma en España varía según el plan de tratamiento elegido. Una consulta inicial con un neurocirujano cuesta alrededor de 470 €, mientras que los diagnósticos preoperatorios, incluidas las resonancias magnéticas y las tomografías PET, varían de 2.540 € a 4.140 €. El procedimiento neuroquirúrgico, que implica neuronavegación avanzada y resección guiada por fluorescencia, se estima entre 46.020 € y 51.680 €. Además, las imágenes postoperatorias pueden aumentar el costo total, con un precio de aproximadamente 1.220 €. Las sesiones de rehabilitación varían de 94 € a 160 € cada una. El plan de tratamiento final y los costos se determinan después de la evaluación de un especialista.
El Dr. Javier Herrero Jover es pionero en la planificación quirúrgica 3D, aportando más de 30 años de experiencia al Centro Médico Teknon.
El Dr. Bartolomé Oliver es pionero en neurocirugía mínimamente invasiva, habiendo realizado más de 900 tratamientos de tumores cerebrales con técnicas avanzadas.
El Dr. Graupera desarrolló un tratamiento pasivo para los gliomas de la médula espinal sin radioterapia, un gran avance en oncología pediátrica. Jefe del Departamento de Hematología y Oncología de Sant Joan De Déu.
Pionero en la definición de criterios estrictos para los síndromes neurológicos paraneoplásicos: el Dr. Graus es una figura líder en neurooncología en el Hospital Quiron Barcelona.
Patients choose Spain for glioma treatment to access advanced neuro-oncology protocols like fluorescence-guided surgery and Tumor Treating Fields. Spanish centers provide faster access to urgent interventions. JCI-accredited facilities in Barcelona and Madrid offer specialized care from neurosurgeons with over 40 years of experience.
Bookimed Expert Insight: Data shows Spain is a top destination for complex neurosurgery, ranking 3rd globally in our network. While many focus on surgery, the real value is in the integrated diagnostics. For example, packages at Hospital Ruber Internacional include PET-CT and angiography alongside surgery. This comprehensive approach often saves patients 7-10 days in the critical planning phase.
Patient Consensus: Patients note that avoiding long wait times for biopsies and imaging is a primary motivator. Many emphasize that the ability to secure online consultations within 24 hours provides vital peace of mind when facing urgent tumor progression.
Top-rated hospitals for glioma treatment in Spain include Centro Medico Teknon, Hospital Ruber Internacional, and Clinica Universidad de Navarra. These JCI-accredited centers specialize in fluorescence-guided resection. They utilize advanced technologies like Gamma Knife and TrueBeam to maximize tumor removal while preserving neurological function.
Bookimed Expert Insight: While hospital reputation is important, our data reveals that specialized neuro-oncology packages often include vital diagnostics like PET-CT and MRI. For instance, Hospital Ruber Internacional offers a $35,000 comprehensive Gamma Knife package, whereas Teknon provides targeted radiosurgery for $16,000. Choosing based on the specific neurosurgeon’s annual glioma volume often ensures better functional outcomes after complex resections.
Patient Consensus: Patients emphasize finding a hospital with a dedicated multidisciplinary tumor board. They note that quick response times for second opinions and fast MRI scheduling are essential for managing aggressive brain tumors.
Spain is a top European neuro-oncology hub. Facilities offer Gamma Knife radiosurgery, MR-Linac guided therapies, and awake craniotomies for gliomas. Specialized centers utilize fluorescence-guided surgery to maximize tumor resection. Patients can access innovative dendritic cell vaccines and genetic trials for glioblastoma treatment.
Bookimed Expert Insight: While standard treatments are widely available, the infrastructure in Spain allows for faster access to radiosurgery. For instance, Hospital Ruber Internacional and Centro Médico Teknon report high volumes for Gamma Knife and Truebeam. This suggests centers prioritize non-invasive options for early-stage or deep-seated tumors. Patients often save time by coordinating diagnostics like PET-CT and MRI in 1-day bundles at these clinics.
Patient Consensus: Patients emphasize the value of getting a second opinion from major university hospitals. They note that having full molecular profiling for markers like IDH and MGMT is essential for qualifying for the latest targeted trials.